Tags: Chemical Compound, Chemical Substance.

UK-432097 is a drug developed by Pfizer for the treatment of chronic obstructive pulmonary disease which acts as a potent and selective agonist of the adenosine A2A receptor. It was discontinued from clinical trials following poor efficacy results but its high selectivity has made it useful for detailed mapping of the internal structure of the A2A receptor.

UK-432097.svg
IUPAC name
6-(22-diphenylethylamino)-9-((2R3R4S5S)-5-(ethylcarbamoyl)-34-dihydroxytetrahydrofuran-2-yl)-N-(2-(3-(1-(pyridin-2-yl)piperidin-4-yl)ureido)ethyl)-9H-purine-2-carboxamide

Loading...

This page contains content from the copyrighted Wikipedia article "UK-432097"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.